- Home
- NAUT vs AGL Comparison
NAUT vs AGL Comparison
Compare NAUT & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | AGL |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.4M | 270.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAUT | AGL |
|---|---|---|
| Price | $1.86 | $0.72 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $2.79 |
| AVG Volume (30 Days) | 337.1K | ★ 10.5M |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,885,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $0.62 | $0.51 |
| 52 Week High | $2.54 | $6.08 |
Technical Indicators
Market Signals| Indicator | NAUT | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 52.67 |
| Support Level | $1.96 | $0.64 |
| Resistance Level | $2.13 | $0.72 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 5.86 | 91.14 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.